Luseogliflozin effective for T2DM with low-carb, high-carb diet
(HealthDay)—For patients with type 2 diabetes (T2D), the SGLT2 inhibitor luseogliflozin has similar efficacy when meals contain 40 to 55 percent total energy from carbohydrate (TEC), according to a study published online ...
Dec 29, 2016
0
0